@article{article, title  = {{Cost-effectiveness (CE) of lapatinib plus capecitabine (L plus C) in women with HER2+metastatic breast cancer (MBC) who received prior therapy with trastuzumab (TZ) based on updated survival data from EGF100151}},

 url = {{}},

 year = {{2008}},

 month = {{5}},

 author = {{DeLea T and Tappenden P and Sofrygin O and Karnon J and Amonkar M and Browning D and Rudge HJ and Walker MD}},

 doi = {{10.1200/jco.2008.26.15_suppl.6559}},

 volume = {{26}},

 journal = {{JOURNAL OF CLINICAL ONCOLOGY}},

 issue = {{15}},

 note = {{Accessed on 2025/04/05}}}